news aktuell GmbH

Egypt Captures Attention at ITB China 2025 with Strong Tourism Growth and Strategic Vision

30.5.2025 08:54:36 CEST | news aktuell GmbH | Pressmeddelande

Dela
Egypt Captures Attention at ITB China 2025 with Strong Tourism Growth and Strategic Vision
Egypt Captures Attention at ITB China 2025 with Strong Tourism Growth and Strategic Vision

Shanghai, China – 28 May 2025 — Egypt concluded its participation in ITB China 2025 with a high-impact press conference that drew the attention of international media and travel professionals. Led by Ahmed Youssef, the CEO of the Egyptian Tourism Authority, the delegation outlined Egypt’s tourism strategy for the Chinese market—emphasizing Egypt’s latest developments in the country’s tourism sector and future strategy.

Youssef shared that Chinese arrivals to Egypt grew by 60,7% in 2024, with momentum continuing into 2025.

"China is not only an important market," said Youssef. "Our focus is on personalization, accessibility, developing markets, and diversifying product consumption.”

Grand Egyptian Museum to Become Cultural Landmark

At the heart of Egypt’s presentation was the upcoming Grand Egyptian Museum (GEM), officially opening on July 3, 2025. The museum, located just outside Cairo near the famous Pyramids of Giza, will feature over 100.000 artifacts—including the full collection from King Tutankhamun’s tomb, presented for the first time in one place.

The museum’s architectural scale, immersive technology, and cultural ambition were described as defining elements of Egypt’s tourism renaissance. More than 5,000 visitors per day attended its soft-opening phase in 2024, and international interest continues to grow ahead of the grand opening.

"The GEM is not only a symbol of our ancient heritage but a statement of our vision for the future. It represents Egypt’s role as a cultural leader on the world stage," Youssef addressed.

Egypt continues to make significant strides to accommodate the Chinese market...

For more information, please visit this link: https://www.mcgroup.com/egyptian-tourism-authority-press-release 

Kontakter

Bilder

Egypt Captures Attention at ITB China 2025 with Strong Tourism Growth and Strategic Vision
Egypt Captures Attention at ITB China 2025 with Strong Tourism Growth and Strategic Vision
Ladda ned bild

Följ news aktuell GmbH

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från news aktuell GmbH

Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release

New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release

Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye